N/A
N=54
The Role of Skin Care Regimen in Skin Health
Itching · Xerosis
Bottom Line
View on ClinicalTrials.gov: NCT03497130 ↗Enrolled (actual)
54
Serious AEs
0.0%
Results posted
May 2020
Primary outcome: Primary: Change in Total Clinical Score (TCS) Between the Final Visit and Baseline — -4; -2 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- skin care regimen (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Johns Hopkins University
- Primary completion
- Apr 2020
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Total Clinical Score (TCS) Between the Final Visit and Baseline |
-4; -2 | — |
| PRIMARY Change in Visual Dryness 5-point Severity Score for Total Body Score Between the Final Visit and the Baseline |
-4; -3 | — |
| SECONDARY Change in Frequency of Itchy-specific Quality-of-life (ItchyQoL) Score Between the Final Visit and Baseline |
-3; 0; -1; 0; -1; 0 | — |
Summary
This research is being done to evaluate the role of a regular skin care regimen comprising of a mild soap and moisturizer in improving dry skin and overall skin health. In this study, the investigators hope to learn the importance of regular skin care regimen in improving dry skin and overall skin health.
Eligibility Criteria
Inclusion Criteria
- Participants must be over the age of 18 years old with dry, itchy skin;
- Participant must be willing to comply with the requirements of the protocol;
- Participant must have the ability to understand and communicate with the investigator;
- Participant must provide informed consent.
Exclusion Criteria
- Subjects who are unable to provide informed consent;
- Subjects who are unable to refrain from swimming or hot tub use throughout the study duration
- Subject with significant medical history or current skin diseases that the investigator feels is not safe for study participation;
- Subjects who have been treated with systemic retinoids or steroids within the past month prior to entry to the study;
- Subjects who have been treated with topical steroids, retinoids or other topical drugs within 2 weeks prior to entry to the study;
- Recently treated or current skin diseases that would affect clinical evaluation;
- Subjects who self-report that they are pregnant or nursing;
- Patients with history of investigational drug use in the 30 days prior to entry into the study.
Data sourced from ClinicalTrials.gov (NCT03497130). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.